RARA and breast carcinoma: RARA itself is activated by ERα (Estrogen Receptor‐α), and the specific binding site has been confirmed to fall within the first intron of RARA in humans using chromatin immunoprecipitation (ChIP) cloning of human breast cancer cells (Laganière et al., 2005).